CompletedEarly Phase 1NCT04901715

Functional Studies of Novel Genes Mutated in Primary Ciliary Dyskinesia II: Genotype to Phenotype

Studying Primary ciliary dyskinesia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of North Carolina, Chapel Hill
Principal Investigator
Lawrence Ostrowski, PhD
University of North Carolina at Chapel Hil
Intervention
Albuterol(drug)
Enrollment
27 enrolled
Eligibility
12-90 years · All sexes
Timeline
20212024

Study locations (1)

Collaborators

National Heart, Lung, and Blood Institute (NHLBI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04901715 on ClinicalTrials.gov

Other trials for Primary ciliary dyskinesia

Additional recruiting or active studies for the same condition.

See all trials for Primary ciliary dyskinesia

← Back to all trials